Platelet dysfunction in pre-eclamptic mothers

2016-07-13T08-31-58Z
Source: International Journal of Medical Science and Public Health
Purnima Meher, Sunil Kumar Jena, Sitanshu Kumar Meher.
Background: Pre-eclampsia (PE) is a pregnancy-specific hypertensive disorder leading to a high proportion of hospital admission, labor induction, maternal as well as fetal morbidity and mortality. However it is fortunate that with timely detection and prompt management, this disease can often be ameliorated and eclampsia can be prevented. Objective: The objective of this study is to find out the changes in total platelet count (TPC), bleeding time (BT), and clotting time (CT) in pre-eclamptic pregnant women as compared with normal pregnant women. Material and Methods: This was a casecontrol study which included 60 pregnant women of more than 20 weeks of gestation. Out of these, 30 subjects were normotensive and 30 subjects were diagnosed with pre-eclamptic women. Patients having a past history of hypertension, renal diseases, diabetes during non-pregnant state, drug administration altering hematological profile, and autoimmune disorder were excluded from the study. Blood pressure was measured in all the cases and control subjects and three blood tests, i.e., BT, CT, and TPC were performed for each. Results: There was a significant fall in TPC in PE cases as compared with normal (P

from Scope via xlomafota13 on Inoreader http://ift.tt/2a9ssKk
via IFTTT